| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $1.1M | — | +164.1% |
| SG&A Expense | $2.9M | — | +188.9% |
| Operating Income | -$4.0M | — | -586.5% |
| Interest Expense | $500K | — | +0.0% |
| Net Income | -$3.5M | — | -208.6% |
| EPS (Basic) | -$2.05 | — | -978.9% |
| EPS (Diluted) | -$2.05 | — | -978.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $375K | -78.9% | — |
| Current Assets | $662K | -82.4% | +947.8% |
| Total Assets | $862K | -77.2% | -56.5% |
| Current Liabilities | $29.0M | +30.4% | +118.9% |
| Total Liabilities | $29.1M | -4.5% | +103.2% |
| Stockholders' Equity | -$28.2M | -5.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.6M | — | -610.7% |
| Capital Expenditures | $5K | — | — |
| Investing Cash Flow | $1.1M | — | -82.4% |
| Financing Cash Flow | $28K | — | +100.5% |
| Free Cash Flow | -$2.6M | — | — |
| -97.2% |